Natasha Kaye > Cooley (UK) LLP > London, England > Lawyer Profile
Cooley (UK) LLP Offices
69 OLD BROAD STREET
- Go to...
Mergers & Acquisitions
Natasha Kaye is a partner in Cooley’s London office. Natasha has a broad corporate tax advisory and transactional practice, advising businesses and individuals on UK and international direct and indirect tax issues in relation to corporate, real estate, outsourcing and IP transactions and planning.
Natasha has a particular focus on private equity transactions, advising both institutions and management teams, as well as advising more generally on M&A, reorganisations, joint ventures and corporate restructurings. In relation to real estate, she advises UK and offshore clients on complex fund structures for property investment and development, acquisitions and disposals, joint ventures and landlord and tenant issues.
Natasha serves on Cooley’s management committee. She is also a member of the LexisPSL Tax Consulting Editorial Board.
Natasha joined Cooley in 2015 having been at Olswang for 18 years.
- Stamp Taxes Practitioners Group
- University of London, Queen Mary and Westfield College
- College of Law, London
- University of Leeds
LLB (Hons), 1996
The ‘very approachable and practical‘ team at Cooley (UK) LLP has a wealth of knowledge of the life sciences and technology sectors, where it can draw on the firm’s overarching expertise in private equity and capital markets transactions. The group is led by Natasha Kaye, who focuses on tax issues arising from private equity transactions. David Wilson is also recommended.
Top Tier Firm Rankings
- Dispute resolution > Commercial litigation: mid-market
- Corporate and commercial > Equity capital markets - mid-high cap
- TMT (technology, media and telecoms) > IT and telecoms
- Insurance > Product liability: defendant
- Dispute resolution > Public international law
- Industry focus > TMT
- Crime, fraud and licensing > Fraud: white-collar crime (advice to individuals)
- Insurance > Insurance and reinsurance litigation
- Industry focus > Life sciences and healthcare
- Corporate and commercial > M&A: lower mid-market deals, £50m-£500m
- Corporate and commercial > Private equity: transactions - mid-market deals (up to £250m)
- Dispute resolution > Commercial litigation: premium
- Employment > Employee share schemes
- Insurance > Insurance: corporate and regulatory
- Corporate and commercial > Venture capital
- Crime, fraud and licensing > Fraud: civil
- Dispute resolution > International arbitration
- Corporate and commercial > Corporate tax
- Corporate and commercial > EU and competition